Delcath Systems

[11:07 AM] Leigh Nickens
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of metastatic liver cancers. The Company's proprietary products, HEPZATO KIT (melphalan for Injection/Hepatic Delivery System), are approved for use in the United States by the FDA, and CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP), designated under the medical device regulation for use in Europe and the United Kingdom.